ReShape Lifesciences Files 8-K on Shareholder Vote
Ticker: HIND · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Reshape Lifesciences Inc. (HIND) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance, 8-k
TL;DR
RESHAPE shareholders voted on something important July 24th. 8-K filed.
AI Summary
ReShape Lifesciences Inc. filed an 8-K on July 25, 2025, reporting on a matter submitted to a vote of security holders on July 24, 2025. The company, formerly known as Obalon Therapeutics Inc., is incorporated in Delaware and headquartered in San Clemente, California.
Why It Matters
This filing indicates a significant event involving shareholder decisions, which could impact the company's strategic direction or governance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- ReShape Lifesciences Inc. (company) — Registrant
- Obalon Therapeutics Inc. (company) — Former company name
- July 24, 2025 (date) — Date of earliest event reported
- July 25, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- San Clemente, California (location) — Company headquarters
FAQ
What specific matter was submitted to a vote of ReShape Lifesciences Inc. security holders?
The filing does not specify the exact matter voted upon, only that a submission to a vote of security holders occurred on July 24, 2025.
When was this 8-K report filed with the SEC?
The report was filed on July 25, 2025.
What was ReShape Lifesciences Inc. formerly known as?
The company was formerly known as Obalon Therapeutics Inc.
In which state is ReShape Lifesciences Inc. incorporated?
ReShape Lifesciences Inc. is incorporated in Delaware.
What is the principal executive office address for ReShape Lifesciences Inc.?
The principal executive offices are located at 18 Technology Drive, Suite 110, Irvine, CA 92618.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding ReShape Lifesciences Inc. (HIND).